Doctor profile · Federal record
Dr. Robert Oglesby, MD
Rheumatology Physician (CMS: Rheumatology) · Greenville, NC
- NPI 1568519288
- Accepts Medicare
- MIPS 91.9 / 100 · 2023
- 38 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2355 Hemby Ln
Greenville, NC 278343776
(252) 321-8474
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- November 9, 2020
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- North Carolina #2008-01997
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568519288. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
67,677
Distinct HCPCS
10
Medicare allowed
$2,217,418
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22,100 | 23 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 12,710 | 43 | $33 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 10,250 | 11 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 5,580 | 54 | $23 | |
J9312 |
Injection, rituximab, 10 mg | 3,300 | 11 | $80 | |
J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 960 | 14 | $9 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 918 | 347 | $123 | |
86235 |
Measurement of antibody for assessment of autoimmune disorder, any method | 896 | 124 | $18 | |
36415 |
Insertion of needle into vein for collection of blood sample | 888 | 307 | $7 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 844 | 311 | $8 |
In context: peer comparison
Among 3 peers in Greenville Rheumatology Physician, average services per provider: 742. This provider delivers 91× the peer median.Open Payments
Industry payments received
All-time total
$548
Transactions
11
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ucb, INC. | 1 | $137.89 | |
| Abbvie INC. | 1 | $118.17 | |
| GlaxoSmithKline, LLC. | 4 | $90.55 | |
| Boston Scientific Corporation | 2 | $72.04 | |
| Janssen Biotech, INC. | 1 | $54.99 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $45.74 | |
| Amgen INC. | 1 | $29.10 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,048
Patients
724
Total drug cost
$94,620
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 614 | 124 | $36,459 |
| Methotrexate (Methotrexate Sodium) | Brand | 562 | 118 | $21,922 |
| Tramadol Hcl | Generic | 286 | 60 | $2,719 |
| Prednisone | Generic | 245 | 86 | $1,613 |
| Alendronate Sodium | Generic | 215 | 49 | $1,925 |
| Gabapentin | Generic | 178 | 46 | $2,199 |
| Diclofenac Sodium | Generic | 125 | 55 | $7,021 |
| Allopurinol | Generic | 117 | 29 | $1,885 |
| Celecoxib | Generic | 117 | 28 | $4,835 |
| Leflunomide | Generic | 116 | 25 | $6,713 |
Frequently asked questions
What is Dr. Robert Oglesby's medical specialty?
Dr. Robert Oglesby practices Rheumatology Physician in Greenville, NC.
Where does Dr. Robert Oglesby practice?
Dr. Robert Oglesby practices at 2355 Hemby Ln, Greenville, NC 278343776. Office phone: 2523218474.
What is Dr. Robert Oglesby's NPI?
Dr. Robert Oglesby's National Provider Identifier (NPI) is 1568519288, issued by NPPES.
Does Dr. Robert Oglesby accept Medicare assignment?
Yes. Dr. Robert Oglesby accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Robert Oglesby commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.